BRIEF-AstraZeneca Says Trixeo Aerosphere Approved In The EU For COPD

Reuters | Updated: 14-12-2020 13:05 IST | Created: 14-12-2020 12:56 IST
BRIEF-AstraZeneca Says Trixeo Aerosphere Approved In The EU For COPD
Representative image Image Credit: Twitter (@AstraZeneca)

AstraZeneca PLC:

* ASTRAZENECA PLC - TRIXEO AEROSPHERE APPROVED IN THE EU FOR COPD

* ASTRAZENECA - APPROVAL BY EUROPEAN COMMISSION WAS BASED ON POSITIVE RESULTS FROM ETHOS PHASE III TRIAL Source text for Eikon: Further company coverage:

TRENDING

1
UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks in Court

UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks i...

Global
2
Hormuz Shock Forces a Rethink of How the World Secures Energy

Hormuz Shock Forces a Rethink of How the World Secures Energy

Global
3
EXCLUSIVE-Anthropic leaders to control AI lab via 'Founder LLC' to promote public good over market forces

EXCLUSIVE-Anthropic leaders to control AI lab via 'Founder LLC' to promote p...

Global
4
EXCLUSIVE-Anthropic's IPO prospectus shows sweeping AI vision, surging costs

EXCLUSIVE-Anthropic's IPO prospectus shows sweeping AI vision, surging costs

Global

PERSPECTIVES AND INSIGHTS

Beyond the AI Hype: Sierra Leone Bets on Data, Skills and Connectivity to Drive Real Development

Eurasia’s Middle Corridor Faces a $55 Billion Test to Turn Connectivity Into Economic Growth

The Double-Edged Network: How Global Trade Shares Risk and Spreads Contagion

AI, ESG and Trust Are Becoming Interdependent Pillars of Digital Finance

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026